Hippocrates and prozac: The controversy about antidepressants in bipolar disorder

Primary Psychiatry

Volumn 13, Issue 11, 2006, Pages 51-58

  Ghaemi, S Nassir ^a,b  

^a EMORY UNIVERSITY   (United States)

^b EMORY CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; FLUOXETINE; IMIPRAMINE; LITHIUM; MOOD STABILIZER; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

BIPOLAR DISORDER; CLINICAL PRACTICE; CLINICAL TRIAL; CONFERENCE PAPER; CONFLICT; DRUG EFFICACY; DRUG INDICATION; HAPPINESS; HUMAN; MEDICAL ETHICS; META ANALYSIS; OUTCOMES RESEARCH; PATIENT ATTITUDE; PHILOSOPHY; PHYSICIAN ATTITUDE; PRACTICE GUIDELINE; PSYCHIATRIST; PSYCHOPHARMACOLOGY; RISK BENEFIT ANALYSIS; SEXUAL DYSFUNCTION; SUICIDAL BEHAVIOR; SYSTEMATIC REVIEW; UNITED STATES; UNSPECIFIED SIDE EFFECT; WELLBEING;

EID: 33845230386     PISSN: 10826319     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (58)

1. Galbraith JK. A Tenured Professor, Boston, MA: Houghton-Mifflin; 2001:34.
2. Ghaemi SN, Ko JY, Goodwin FK. "Cade's disease" and beyond: misdiagnosis, antidepressant use, and a proposed definition for bipolar spectrum disorder. Can J Psychiatry. 2002;47(2):125-134.
3. Ghaemi SN, Hsu DJ, Soldani F, Goodwin FK. Antidepressants in bipolar disorder: the case for caution. Bipolar Disord. 2003;5(6):421-433.
4. Goldberg JF, Ghaemi SN. Benefits and limitations of antidepressants and traditional mood stabilizers for treatment of bipolar depression. Bipolar Disord. 2005;7(suppl 5):3-12.
5. Goldstein JE. Console and Classify: The French Psychiatric Profession in the Nineteenth Century. Chicago, IL: University of Chicago Press; 2002.
6. Valenstein ES. Great and Desperate Cures: The Rise and Decline of Psychosurgery and Other Radical Treatments for Mental Illness. New York, NY: Harper Collins; 1987.
7. Saggese JM, Lieberman DZ, Goodwin FK. The role of recurrence and cyclicity in differentiating mood disorder diagnoses. Primary Psychiatry. 2006;13(11):43-48.
8. Goodwin FK, Ghaemi SN. An introduction to and history of affective disorders. In: Gelder M, Lopez-Ibor J, Andreasen N, eds. New Oxford Textbook of Psychiatry. Vol I. New York, NY: Oxford University Press; 2000:677-682.
9. Perris C. A study of bipolar (manic-depressive) and unipolar recurrent depressive psychoses. I-VIII. Acta Psychiatr Scand Suppl. 1966;194:15-152.
10. Diagnostic and Statistical Manual of Mental Disorders. 3rd ed. Washington, DC: American Psychiatric Association; 1980.
11. Kramer PD. Listening to Prozac. New York, NY: Viking; 1993.
12. Healy D. The Antidepressant Era. Cambridge, MA: Harvard University Press; 1998.
13. Angell M, ed. The Truth About the Drug Companies. New York, NY: Random House; 2005.
14. Hammad TA, Laughren T, Racoosin J. Suicidality in pediatric patients treated with antidepressant drugs. Arch Gen Psychiatry. 2006;63(3):332-339.
15. Wright R. Is Prozac driving Wall Street? Slate.com. March 3, 2000. Available at: www.slate.com/id/76624/. Accessed September 21, 2006.
16. Whybrow P. American Mania. New York, NY: Norton; 2006.
17. Graham MG, ed. Sleep Needs, Patterns, and Difficulties of Adolescents: Summary of a Workshop. Washington, DC: National Academies Press; 2000.
18. Galbraith JK. The Affluent Society. New York, NY: Mentor Books; 1958.
19. Ghaemi SN. The Concepts of Psychiatry. Baltimore, MD: Johns Hopkins University Press; 2003.
20. Ghaemi SN. Mood Disorders: A Practical Guide. Philadelphia, PA: Lippincott Williams and Wilkins; 2003.
21. Koukopoulos A, Reginaldi P, Laddomada G, Floris G, Serra G, Tondo L. Course of the manic-depressive cycle and changes caused by treatments. Pharmacopsychiatry. 1980;13:156-167.
22. Wehr TA, Goodwin FK. Can antidepressants cause mania and worsen the course of affective illness? Am J Psychiatry. 1987;144(11):1403-1411.
23. Wehr TA, Sack DA, Rosenthal NE, Cowdry RW. Rapid cycling affective disorder: contributing factors and treatment responses in 51 patients. Am J Psychiatry. 1988;145(2):179-184.
24. Altshuler LL, Post RM, Leverich GS, Mikalauskas K, Rosoff A, Ackerman L. Antidepressant-induced mania and cycle acceleration: a controversy revisited. Am J Psychiatry. 1995;152(8):1130-1138.
25. Goodwin FK, Jamison KR. Manic-Depressive Illness. New York, NY: Oxford University Press; 1990.
26. Ghaemi SN, Sachs GS, Chiou AM, Pandurangi AK, Goodwin K. Is bipolar disorder still underdiagnosed? Are antidepressants overutilized? J Affect Disord. 1999;52(1-3):135-144.
27. Ghaemi SN, Boiman EE, Goodwin FK. Diagnosing bipolar disorder and the effect of antidepressants; a naturalistic study. J Clin Psychiatry. 2000;61(10):804-808.
28. Ghaemi SN, Ko JY, Rosenquist KR, Baldessarini RJ. Worse antidepressant outcomes in bipolar than unipolar depression. Paper presented at: 155th Annual Meeting of the American Psychiatric Association; May 18-23, 2002; Philadelphia, PA.
29. Koukopoulos A, Sni G, Koukopoulos A, Girardi P. Cyclicity and manic-depressive illness. In: Marneros A, Angst J, eds. Bipolar Disorders: 100 Years After Manic-Depressive Insanity. London, UK: Kluwer Academic Publishers; 2000:315-334.
30. Altshuler L, Kiriakos L, Calcagno J, et al. The impact of antidepressant discontinuation versus antidepressant continuation on 1-year risk for relapse of bipolar depression: a retrospective chart review. J Clin Psychiatry. 2001;62(8):612-616.
31. Altshuler L, Suppes T, Black D, et al. Impact of antidepressant discontinuation after acute bipolar depression remission on rates of depressive relapse at 1-year follow-up. Am J Psychiatry. 2003;160(7):1252-1262.
32. Joffe RT, MacQueen GM, Marriott M, Young LT. One-year outcome with antidepressant - treatment of bipolar depression. Acta Psychiatr Scand. 2005;112(2):105-109.
33. Coryell W, Solomon D, Turvey C, et al. The long-term course of rapid-cycling bipolar disorder. Arch Gen Psychiatry. 2003;60(9):914-920.
34. Prien RF, Kupfer DJ, Mansky PA, et al. Drug therapy in the prevention of recurrences in unipolar and bipolar affective disorders: A report of the NIMH Collaborative Study Group comparing lithium carbonate, imipramine, and a lithium carbonate-imipramine combination. Arch Gen Psychiatry. 1984;41(11):1096-1104.
35. Ghaemi SN, El-Mallakh RS, Baldassano CF, et al. A randomized clinical trial of efficacy and safety of long-term antidepressant use in bipolar disorder [abstract]. Bipolar Disord. 2005;7(suppl 2):59.
36. Gijsman HJ, Geddes JR, Rendell JM, Nolen WA, Goodwin GM. Antidepressants for bipolar depression: a systematic review of randomized, controlled trials. Am J Psychiatry. 2004;161(9):1537-1547.
37. Nemeroff CB, Evans DL, Gyulai L, et al. Double-blind, placebo-controlled comparison of imipramine and paroxetine in the treatment of bipolar depression. Am J Psychiatry. 2001;158(6):906-912.
38. Goldberg J, Whiteside J. The association between substance abuse and antidepressant-induced mania in bipolar disorder: a preliminary study. J Clin Psychiatry. 2002;63(9):791-795.
39. Prien RF, Klett CJ, Caffey EM. Lithium carbonate and imipramine in prevention of affective episodes. A comparison in recurrent affective illness. Arch Gen Psychiatry. 1973;29(3):420-425.
40. Wehr T, Goodwin F. Rapid cycling in manic-depressives induced by tricyclic antidepressants. Arch Gen Psychiatry. 1979;36(5):555-559.
41. Quitkin FM, Kane J, Rifkin A, Ramos-Lorenzi JR, Nayak DV. Prophylactic lithium carbonate with and without imipramine for bipolar 1 patients. A double-blind study. Arch Gen Psychiatry. 1981;38(8):902-907.
42. Spitzer R, Endicott J, Robins E. Research diagnostic criteria. Psychopharmacol Bull. 1975;11(3):22-25.
43. Kane JM, Quitkin FM, Rifkin A, Ramos-Lorenzi JR, Nayak DD, Howard A. Lithium carbonate and imipramine in the prophylaxis of unipolar and bipolar II illness: a prospective, placebo-controlled comparison. Arch Gen Psychiatry. 1982;39(9):1065-1069.
44. Sachs GS, Lafer B, Stoll AL, et al. A double-blind trial of bupropion versus desipramine for bipolar depression. J Clin Psychiatry. 1994;55(9):391-393.
45. Diagnostic and Statistical Manual of Mental Disorders. 3rd ed rev. Washington, DC: American Psychiatric Association; 1987.
46. Amsterdam JD, Garcia-Espana F, Fawcett J, et al. Efficacy and safety of fluoxetine in treating bipolar II major depressive episode. J Clin Psychopharmacol. 1998;18:435-440.
47. Leverich GS, Altshuler LL, Frye MA, et al. Risk of switch in mood polarity to hypomania or mania in patients with bipolar depression during acute and continuation trials of venlafaxine, sertraline, and bupropion as adjuncts to mood stabilizers. Am J Psychiatry. 2006;163(2):232-239.
48. Practice guidelines for the treatment of patients with bipolar disorder. American Psychiatric Association. Am J Psychiatry. 1994;151(12 suppl):1-36.
49. Hirschfeld RM, Bowden CL, Gitlin MJ, et al. American Psychiatric Association practice guideline for the treatment of patients with bipolar disorder (revision). Am J Psychiatry. 2002;159(suppl):1-50.
50. Grunze H, Kasper S, Goodwin G, et al. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of bipolar disorders. Part I: Treatment of bipolar depression. World J Biol Psychiatry. 2002;3(3):115-124.
51. Moller HJ, Grunze H. Have some guidelines for the treatment of acute bipolar depression gone too far in the restriction of antidepressants? Eur Arch Psychiatry Clin Neurosci. 2000;250(2):57-68.
52. Ghaemi SN, Goodwin FK. Long-term naturalistic treatment of depressive symptoms in bipolar illness with divalproex vs. lithium in the setting of minimal antidepressant use. J Affect Disord. 2001;65(3):281-287.
53. Ghaemi SN. On defining 'mood stabilizer'. Bipolar Disord. 2001;3(3):154-158.
54. Osler W. Aequanimitas. Philadelphia, PA: The Blakiston Company; 1948.
55. McHugh PR. William Osler and the new psychiatry. Ann Intern Med. 1987;107(6):914-918.
56. Holmes OW. Medical Essays 1842-1882; Boston, MA: Houghton-Mifflin; 1891.
57. Jouanna J. Hippocrates. Baltimore, MD: Johns Hopkins University Press; 2001.
58. McHugh PR. Hippocrates a la mode. Nat Med. 1996;2(5):507-509.